STAT3 and hepatocellular carcinoma: When IL-12 was administered to mice with hepatocellular carcinoma, By down regulating STAT3 and its downstream transcription factor c-myc, we can change the functional phenotype of M2 TAMs, so as to reduce the production of tumor cytokines and inhibit the growth of tumors 99.